Flagship Harbor Advisors’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-10,350
| Closed | -$60.4K | – | 657 |
|
|
2022
Q4 | $60.4K | Hold |
10,350
| – | – | 0.01% | 591 |
|
|
2022
Q3 | $69K | Sell |
10,350
-50
| -0.5% | -$333 | 0.01% | 572 |
|
|
2022
Q2 | $44K | Hold |
10,400
| – | – | ﹤0.01% | 582 |
|
|
2022
Q1 | $35K | Hold |
10,400
| – | – | ﹤0.01% | 612 |
|
|
2021
Q4 | $33K | Sell |
10,400
-3,500
| -25% | -$11.1K | ﹤0.01% | 640 |
|
|
2021
Q3 | $59K | Hold |
13,900
| – | – | 0.01% | 619 |
|
|
2021
Q2 | $59K | Buy |
13,900
+2,500
| +22% | +$10.6K | 0.01% | 621 |
|
|
2021
Q1 | $57K | Buy |
+11,400
| New | +$57K | 0.01% | 612 |
|
|
2020
Q4 | – | Sell |
-4,000
| Closed | -$39K | – | 1875 |
|
|
2020
Q3 | $39K | Hold |
4,000
| – | – | 0.01% | 933 |
|
|
2020
Q2 | $39K | Sell |
4,000
-400
| -9% | -$3.9K | 0.01% | 925 |
|
|
2020
Q1 | $39K | Sell |
4,400
-600
| -12% | -$5.32K | 0.01% | 827 |
|
|
2019
Q4 | $46K | Hold |
5,000
| – | – | 0.01% | 844 |
|
|
2019
Q3 | $29K | Buy |
5,000
+3,100
| +163% | +$18K | 0.01% | 959 |
|
|
2019
Q2 | $22K | Hold |
1,900
| – | – | ﹤0.01% | 1044 |
|
|
2019
Q1 | $22K | Hold |
1,900
| – | – | ﹤0.01% | 1037 |
|
|
2018
Q4 | $23K | Hold |
1,900
| – | – | 0.01% | 963 |
|
|
2018
Q3 | $27K | Hold |
1,900
| – | – | 0.01% | 1025 |
|
|
2018
Q2 | $31K | Buy |
+1,900
| New | +$31K | 0.01% | 957 |
|